NCT03491085

Brief Summary

morbidity after tonsillictomy remains asignificant problem therefore they recommend prophylactic antibiotics to reduce it.in the other hand, the overuse of antimicrobial agents can lead to antimicrobial resistance ,adverse drug events,and unnecessary cost.so,the effectiveness and necessity of antibiotic following tonsillictomy needs to be studied .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 9, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

May 15, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2020

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

1.7 years

First QC Date

March 16, 2018

Last Update Submit

May 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • compare the morbidity after tonsillectomy between the group which receive antibiotics and the other group which not receive antibiotics

    A questionnaire will be given to the parents on discharge to fill in the type of post-tonsillectomy morbidity of main concern including: fever, secondary bleeding, number of days with throat pain and the number of days to resume normal diet, incidence of abdominal pain, nausea \& vomiting.

    2 years

Study Arms (2)

tonsillictomy with antibiotics

ACTIVE COMPARATOR
Drug: Amoxicillin/clavulanate

tonsillictomy Without Antibiotics

NO INTERVENTION

Interventions

after tonsillectomy half of our patients will receive Amoxicillin /clavulanate for one week and the other half will not receive it.

tonsillictomy with antibiotics

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients who are scheduled for tonsillectomy with or without adenoidectomy, and their age are less than 18 years old of either gender will be included in our study

You may not qualify if:

  • Patients age ≥ 18 years.
  • Trials in which antibiotics was administrated locally or used in the immediate preoperative period (within seven days before surgery).
  • \. Medical comorbidity requiring treatment with antibiotics e.g. Rheumatic heart disease
  • Patients undergoing the following procedures:
  • Unilateral tonsillectomy or biopsy.
  • Tonsillectomy for known carcinoma.
  • Tonsillectomy in conjunction with palatal surgery.
  • Hot tonsillectomy for tonsillar abscess

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Patel A, Foden N, Rachmanidou A. Is weekend surgery a risk factor for post-tonsillectomy haemorrhage? J Laryngol Otol. 2016 Aug;130(8):763-7. doi: 10.1017/S0022215116008161. Epub 2016 Jun 13.

    PMID: 27292442BACKGROUND

MeSH Terms

Interventions

Amoxicillin-Potassium Clavulanate Combination

Intervention Hierarchy (Ancestors)

Clavulanic AcidClavulanic Acidsbeta-LactamsLactamsAmidesOrganic ChemicalsAmoxicillinAmpicillinPenicillin GPenicillinsSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsDrug CombinationsPharmaceutical Preparations

Central Study Contacts

ahmed alhussaini, professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 16, 2018

First Posted

April 9, 2018

Study Start

May 15, 2018

Primary Completion

January 15, 2020

Study Completion

March 15, 2020

Last Updated

May 17, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share